Overview

A Study in Two Panels of Healthy Adult Participants to Assess Single-Dose Immediate-Release and Single-Dose Dispersible Formulations of Pretomanid

Status:
Completed
Trial end date:
2020-02-28
Target enrollment:
Participant gender:
Summary
This is a single-dose, open-label, randomized, four-period, four-treatment, crossover study in healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Global Alliance for TB Drug Development